170 related articles for article (PubMed ID: 14981648)
1. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
Berchi C; Bouvier V; Réaud JM; Launoy G
Health Econ; 2004 Mar; 13(3):227-38. PubMed ID: 14981648
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.
Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J
Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening.
Berchi C; Guittet L; Bouvier V; Launoy G
Int J Technol Assess Health Care; 2010 Jan; 26(1):48-53. PubMed ID: 20059780
[TBL] [Abstract][Full Text] [Related]
4. Screening of colorectal cancer.
Winawer SJ
Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness and projected national impact of colorectal cancer screening in France.
Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
[TBL] [Abstract][Full Text] [Related]
6. [Advantage of immunochemical fecal occult blood test in screening for colorectal cancer].
Launoy G; Berchi C
Bull Cancer; 2005 Oct; 92(10):885-90. PubMed ID: 16266872
[TBL] [Abstract][Full Text] [Related]
7. High participation rates are not necessary for cost-effective colorectal cancer screening.
Howard K; Salkeld G; Irwig L; Adelstein BA
J Med Screen; 2005; 12(2):96-102. PubMed ID: 15949121
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
10. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
van Veen W; Mali WP
Ned Tijdschr Geneeskd; 2009; 153():A1441. PubMed ID: 20003552
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
Wong SS; Leong AP; Leong TY
Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
13. Potential impact of population-based colorectal cancer screening in Canada.
Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
[TBL] [Abstract][Full Text] [Related]
14. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
16. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project.
Chen TH; Yen MF; Lai MS; Koong SL; Wang CY; Wong JM; Prevost TC; Duffy SW
Cancer; 1999 Oct; 86(7):1116-28. PubMed ID: 10506694
[TBL] [Abstract][Full Text] [Related]
19. [Cost of a mass screening program for colorectal cancer using the occult blood test].
Arveux P; Faivre J; Bedenne L; Durand G; Milan C; Milan C
Gastroenterol Clin Biol; 1992; 16(6-7):547-51. PubMed ID: 1526416
[TBL] [Abstract][Full Text] [Related]
20. Screening for colorectal cancer.
Hakama M; Hoff G; Kronborg O; Påhlman L
Acta Oncol; 2005; 44(5):425-39. PubMed ID: 16118076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
